Given that numerous studies have shown the role of AQP3 and AQP7 overexpression in promoting breast cancer, the combined inhibition of AQP3 and AQP7 could be a useful strategy in the treatment of breast cancer progression and metastasis [11,14,15,37,38,39,40]. The gene discussed is AQP3; the disease is breast carcinoma.